InvestSMART

Regis Healthcare Limited (ASX: REG) - Announcements

- Current share price for REG : $4.610

ASX company news and announcements for Regis Healthcare Limited (REG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Regis Healthcare Limited (REG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Regis Healthcare Limited (REG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Regis Healthcare Limited (REG)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$1,394 Final Director's Interest Notice 10 Sep 2019 12:26PM $2.745 $4.610 risen by 67.94%
$1,394 Dividend/Distribution - REG 22 Aug 2019 9:09AM $2.880 $4.610 risen by 60.07%
$1,394 Regis Healthcare Investor Presentation FY2019 Results 22 Aug 2019 9:09AM $2.880 $4.610 risen by 60.07%
$1,394 Regis Healthcare Results Announcement FY2019 22 Aug 2019 9:07AM $2.880 $4.610 risen by 60.07%
$1,394 Regis Healthcare Appendix 4E and Financial Report FY2019 22 Aug 2019 9:06AM $2.880 $4.610 risen by 60.07%
$1,394 AGM Date 15 Aug 2019 12:00PM $2.620 $4.610 risen by 75.95%
$1,394 Resignation of Chief Financial Officer 31 Jul 2019 5:02PM $2.800 $4.610 risen by 64.64%
$1,394 Notification of Annual Results FY19 Reporting Date 29 Jul 2019 2:13PM $2.650 $4.610 risen by 73.96%
$1,394 S&P DJI Announces June 2019 Quarterly Rebalance 14 Jun 2019 8:20AM $2.620 $4.610 risen by 75.95%
$1,394 Regis Healthcare Trading Update 6 Jun 2019 10:20AM $2.780 $4.610 risen by 65.83%
$1,394 CEO Appointment 20 May 2019 9:40AM $3.130 $4.610 risen by 47.28%
$1,394 Update on Government Funding Increase 25 Mar 2019 9:47AM $3.500 $4.610 risen by 31.71%
$1,394 Change of Director's Interest Notice 6 Mar 2019 1:07PM $3.130 $4.610 risen by 47.28%
$1,394 Change of Director's Interest Notice 1 Mar 2019 12:45PM $3.150 $4.610 risen by 46.35%
$1,394 Dividend/Distribution - REG 22 Feb 2019 8:28AM $3.380 $4.610 risen by 36.39%
$1,394 Regis Healthcare CEO Stepping Down 22 Feb 2019 8:27AM $3.380 $4.610 risen by 36.39%
$1,394 Regis Healthcare Investor Presentation 1H FY19 Results 22 Feb 2019 8:27AM $3.380 $4.610 risen by 36.39%
$1,394 Regis Healthcare Results Announcement 1H FY19 22 Feb 2019 8:27AM $3.380 $4.610 risen by 36.39%
$1,394 Regis Healthcare 4D and Financial Report 1H FY19 22 Feb 2019 8:26AM $3.380 $4.610 risen by 36.39%
$1,394 Regis - Half Year FY19 Reporting Date 6 Feb 2019 10:37AM $2.980 $4.610 risen by 54.70%
$1,394 Regis Healthcare - UBS Conference 13 Nov 2018 9:45AM $2.640 $4.610 risen by 74.62%
$1,394 Change of Director's Interest Notice 1 Nov 2018 2:31PM $2.430 $4.610 risen by 89.71%
$1,394 Regis Healthcare - Results of Annual General Meeting 25 Oct 2018 1:20PM $2.470 $4.610 risen by 86.64%
$1,394 Regis Healthcare - Chairman and MD addresses to AGM 25 Oct 2018 9:40AM $2.520 $4.610 risen by 82.94%
$1,394 Ceasing to be a substantial holder from CBA 28 Sep 2018 4:48PM $2.890 $4.610 risen by 59.52%

276 - 300 of 407 results

Page 12 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.